Wells Fargo & Company Harrow Health, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Harrow Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 17,422 shares of HROW stock, worth $589,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,422

Previous 35,402 50.79%

Holding current value

$589,386

Previous $739,000 5.95%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$20.85 - $46.47 $374,883 - $835,530	-17,980 Reduced 50.79%	17,422 $783,000
Q2 2024 Aug 13, 2024	BUY	$10.0 - $21.64 $263,220 - $569,608	26,322 Added 289.89%	35,402 $739,000
Q1 2024 May 10, 2024	BUY	$9.3 - $13.23 $11,290 - $16,061	1,214 Added 15.43%	9,080 $120,000
Q4 2023 Feb 09, 2024	BUY	$8.1 - $16.36 $16,135 - $32,589	1,992 Added 33.91%	7,866 $88,000
Q3 2023 Nov 13, 2023	SELL	$14.03 - $22.08 $70,051 - $110,245	-4,993 Reduced 45.95%	5,874 $84,000
Q2 2023 Aug 15, 2023	SELL	$17.37 - $28.08 $883,420 - $1.43 Million	-50,859 Reduced 82.39%	10,867 $206,000
Q1 2023 May 12, 2023	BUY	$13.84 - $21.46 $845,001 - $1.31 Million	61,055 Added 9099.11%	61,726 $1.31 Million
Q4 2022 Feb 13, 2023	BUY	$10.28 - $14.78 $5,181 - $7,449	504 Added 301.8%	671 $9,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $26 - $99	4 Added 2.45%	167 $2,000
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.74 $937 - $1,261	163 New	163 $1,000
Q4 2021 Feb 14, 2022	SELL	$8.5 - $12.0 $1,258 - $1,776	-148 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.99 - $10.6 $44,407 - $67,341	-6,353 Reduced 97.72%	148 $1,000
Q2 2021 Aug 16, 2021	SELL	$6.68 - $11.07 $1.86 Million - $3.08 Million	-278,565 Reduced 97.72%	6,501 $60,000
Q1 2021 May 13, 2021	BUY	$6.26 - $11.03 $1.21 Million - $2.13 Million	193,383 Added 210.93%	285,066 $1.92 Million
Q4 2020 Feb 09, 2021	BUY	$4.76 - $6.93 $145,479 - $211,801	30,563 Added 50.0%	91,683 $630,000
Q3 2020 Nov 05, 2020	BUY	$4.71 - $7.36 $70,612 - $110,341	14,992 Added 32.5%	61,120 $342,000
Q2 2020 Aug 13, 2020	BUY	$3.61 - $6.47 $46,226 - $82,848	12,805 Added 38.43%	46,128 $241,000
Q1 2020 May 14, 2020	BUY	$3.5 - $7.31 $116,630 - $243,591	33,323 New	33,323 $127,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $916M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Harrow Health, Inc. Transaction History